Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479438 · ClinicalTrials.gov registry record
Gastroesophageal Reflux Disease Prospective Registry
A clinical trial, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- 744
- Enrollment target
NCT02479438 is a clinical trial that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 744 participants.
The verdict
NCT02479438 was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- 744 participants
- Enrollment target
Study Summary
The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.
Interventions
- OTHER Diagnosed with GERD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 744 participants |
| Start Date | 2014-01 |
| Est. Completion | 2024-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02479438
The ClinicalTrials.gov registry entry for NCT02479438 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 744 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnosed with GERD is the first listed.
NCT02479438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02479438 about?
NCT02479438 is a clinical study titled "Gastroesophageal Reflux Disease Prospective Registry". The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and ...
What is the current status of trial NCT02479438?
This trial is currently terminated. The enrollment target is 744 participants. The study started on 2014-01. Estimated completion is 2024-09.
What interventions are being tested in trial NCT02479438?
The interventions under investigation include: Diagnosed with GERD (OTHER).
Who is sponsoring clinical trial NCT02479438?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.